几天前，一项来自中国生物技术公司的自研抗体开发技术平台再获海外专利授权，再次点燃了“硬科技出海”的关注热度。 2025年6月5日，百奥赛图宣布，其自主研发的RenMab®全人抗体小鼠平台，获得了由日本专利局（JPO）颁发的发明专利证书。这不仅是对其技术创新能力的高度认可，也标志着中国Biotech企业在全球知识产权竞争中迈出的又一坚实步伐。 而这并非孤例。近年来，越来越多以技术为核心驱动的中国Bi ...

Biotechnology is the application of biological organisms, cells, or molecules to produce a product or service for the betterment of humankind. This area of study includes aspects of molecular biology, ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

The longevity biotechnology industry is rapidly evolving with the amount of academic funding and venture investment increasing at the exponential pace. Over thirty longevity startups and approximately ...

「Debut Biotechnology」宣布公司在B轮融资中获得3400万美元融资，以用于业务范围的扩大。该轮融资由BOLD领投，Fine Structure Ventures、Material Impact、GS Futures、Cavallo Ventures、Cultivian Sandbox Ventures、ACVC Partners等参与。 据悉，Debut Biotechnolog ...

Commentary: Biotechnology lets scientists engineer natural ingredients into products, often more sustainably than if they were farmed. Here's what to know. Deenie is a CNET Perspectives contributor ...

Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...

Legend Biotech develops cell therapies for cancer, with a pipeline spanning hematologic malignancies and solid tumors.